Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010

Hdl Handle:: http://hdl.handle.net/10147/303432
Title:: Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010
Authors:: National Narcolepsy Study Steering Committee
Publisher:: HSE Health Protection Surveillance Centre (HPSC)
Issue Date:: 2010
URI:: http://hdl.handle.net/10147/303432
Item Type:: Report
Language:: en
Description:: In August 2010 the Swedish pharmacovigilance authority reported that it was investigating six cases of narcolepsy reported by health care professionals as a possible adverse event following the use of Pandemrix vaccine, used during the H1N1 2009 pandemic. This was followed shortly by reports from the Finnish National Institute for Health and Welfare (THL) noting there had been a more than expected number of cas es of narcolepsy in children and adolescents that year. On 23rd September, the Committee on Human Medicinal Products (CHMP) of the EMA concluded in its initial re view of available data that the available evidence did not confirm a link but that more research was needed
Keywords:: SLEEP DISORDER; IMMUNISATION; YOUNG PEOPLE

Full metadata record

DC Field	Value	Language
dc.contributor.author	National Narcolepsy Study Steering Committee	en_GB
dc.date.accessioned	2013-10-15T09:25:50Z	-
dc.date.available	2013-10-15T09:25:50Z	-
dc.date.issued	2010	-
dc.identifier.uri	http://hdl.handle.net/10147/303432	-
dc.description	In August 2010 the Swedish pharmacovigilance authority reported that it was investigating six cases of narcolepsy reported by health care professionals as a possible adverse event following the use of Pandemrix vaccine, used during the H1N1 2009 pandemic. This was followed shortly by reports from the Finnish National Institute for Health and Welfare (THL) noting there had been a more than expected number of cas es of narcolepsy in children and adolescents that year. On 23rd September, the Committee on Human Medicinal Products (CHMP) of the EMA concluded in its initial re view of available data that the available evidence did not confirm a link but that more research was needed	en_GB
dc.language.iso	en	en
dc.publisher	HSE Health Protection Surveillance Centre (HPSC)	en_GB
dc.subject	SLEEP DISORDER	en_GB
dc.subject	IMMUNISATION	en_GB
dc.subject	YOUNG PEOPLE	en_GB
dc.title	Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010	en_GB
dc.type	Report	en